← All companies

PHVS

Pharvaris N.V.

PHVS Nasdaq Pharmaceutical Preparations EDGAR ↗

$32.25

-0.37 -1.13%

Key statistics

from XBRL data in SEC filings

Market cap

$2.10B

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$19.56 – $36.60

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jun 26, 2026 6-K Jun 11, 2026 6-K May 12, 2026 6-K May 11, 2026 20-F Apr 2, 2026 6-K Apr 2, 2026 6-K Jan 12, 2026 6-K Dec 3, 2025 6-K Nov 12, 2025 6-K Sep 8, 2025 6-K Aug 12, 2025 6-K Jul 24, 2025 6-K Jul 10, 2025 6-K Jun 27, 2025 6-K Jun 10, 2025 6-K May 13, 2025 6-K Apr 7, 2025 20-F Apr 7, 2025 6-K Jan 13, 2025 6-K Nov 13, 2024 6-K Sep 25, 2024 6-K Sep 23, 2024 6-K Sep 5, 2024 6-K Aug 14, 2024 6-K Jun 28, 2024 6-K Jun 11, 2024 6-K Jun 4, 2024 6-K May 8, 2024 20-F Apr 10, 2024 6-K Apr 10, 2024 6-K Mar 6, 2024 6-K Feb 16, 2024 6-K Feb 7, 2024 6-K Jan 22, 2024 6-K Jan 8, 2024 6-K Dec 8, 2023 6-K Dec 6, 2023 6-K Nov 2, 2023 6-K Aug 7, 2023 6-K Jul 3, 2023